CA2145681A1 - Method for antogonizing inositol 1,4,5-triphosphate - Google Patents
Method for antogonizing inositol 1,4,5-triphosphateInfo
- Publication number
- CA2145681A1 CA2145681A1 CA002145681A CA2145681A CA2145681A1 CA 2145681 A1 CA2145681 A1 CA 2145681A1 CA 002145681 A CA002145681 A CA 002145681A CA 2145681 A CA2145681 A CA 2145681A CA 2145681 A1 CA2145681 A1 CA 2145681A1
- Authority
- CA
- Canada
- Prior art keywords
- inositol
- triphosphate
- calcium
- release
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/795—Polymers containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95239392A | 1992-09-28 | 1992-09-28 | |
US07/952,393 | 1992-09-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2145681A1 true CA2145681A1 (en) | 1994-04-14 |
Family
ID=25492868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002145681A Abandoned CA2145681A1 (en) | 1992-09-28 | 1993-08-30 | Method for antogonizing inositol 1,4,5-triphosphate |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0661982A1 (es) |
JP (1) | JPH08502068A (es) |
KR (1) | KR950703347A (es) |
AU (1) | AU670962B2 (es) |
CA (1) | CA2145681A1 (es) |
HU (1) | HUT70192A (es) |
IL (1) | IL107066A (es) |
MX (1) | MX9305933A (es) |
NO (1) | NO951163L (es) |
NZ (1) | NZ256178A (es) |
TW (1) | TW260663B (es) |
WO (1) | WO1994007507A1 (es) |
ZA (1) | ZA936978B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2978995A (en) * | 1994-06-30 | 1996-01-25 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Methods for treating cell proliferative disorders by modulating signal transduction |
US5780483A (en) * | 1995-02-17 | 1998-07-14 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
WO1996025157A1 (en) | 1995-02-17 | 1996-08-22 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
US6083920A (en) * | 1995-12-21 | 2000-07-04 | Ayurcore, Inc. | Compositions for modulating intracellular inositol trisphosphate concentration |
US6005008A (en) * | 1996-02-16 | 1999-12-21 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
US6211373B1 (en) | 1996-03-20 | 2001-04-03 | Smithkline Beecham Corporation | Phenyl urea antagonists of the IL-8 receptor |
US6262113B1 (en) | 1996-03-20 | 2001-07-17 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
AU3499497A (en) | 1996-06-27 | 1998-01-14 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
TR199802694T2 (xx) * | 1996-06-27 | 1999-03-22 | Smithkline Beecham Corporation | IL-8 resept�r kar��tlar� |
ATE358486T1 (de) * | 2000-11-09 | 2007-04-15 | Contrimmune Biotechnology Inc | Verwendung von xestospongin c zur behandlung oder vorbeugung einer hiv-infektion |
CA2857374A1 (en) | 2011-09-02 | 2013-03-07 | The Trustees Of Columbia University In The City Of New York | Camkii, ip3r, calcineurin, p38 and mk2/3 inhibitors to treat metabolic disturbances of obesity |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB781479A (en) * | 1953-08-27 | 1957-08-21 | Ciba Ltd | New polyureas and process for making them |
US5276182A (en) * | 1990-07-09 | 1994-01-04 | The Dow Chemical Company | Process for preparing polyurea oligomers |
-
1993
- 1993-08-30 CA CA002145681A patent/CA2145681A1/en not_active Abandoned
- 1993-08-30 JP JP6509054A patent/JPH08502068A/ja active Pending
- 1993-08-30 EP EP93921252A patent/EP0661982A1/en not_active Ceased
- 1993-08-30 HU HU9500891A patent/HUT70192A/hu unknown
- 1993-08-30 KR KR1019950701166A patent/KR950703347A/ko not_active Application Discontinuation
- 1993-08-30 WO PCT/US1993/008168 patent/WO1994007507A1/en not_active Application Discontinuation
- 1993-08-30 NZ NZ256178A patent/NZ256178A/en unknown
- 1993-08-30 AU AU48417/93A patent/AU670962B2/en not_active Ceased
- 1993-09-21 ZA ZA936978A patent/ZA936978B/xx unknown
- 1993-09-22 IL IL107066A patent/IL107066A/en not_active IP Right Cessation
- 1993-09-22 TW TW082107787A patent/TW260663B/zh active
- 1993-09-27 MX MX9305933A patent/MX9305933A/es unknown
-
1995
- 1995-03-27 NO NO951163A patent/NO951163L/no unknown
Also Published As
Publication number | Publication date |
---|---|
TW260663B (es) | 1995-10-21 |
AU4841793A (en) | 1994-04-26 |
WO1994007507A1 (en) | 1994-04-14 |
JPH08502068A (ja) | 1996-03-05 |
KR950703347A (ko) | 1995-09-20 |
EP0661982A1 (en) | 1995-07-12 |
NZ256178A (en) | 1997-03-24 |
ZA936978B (en) | 1994-04-18 |
NO951163D0 (no) | 1995-03-27 |
MX9305933A (es) | 1994-04-29 |
HUT70192A (en) | 1995-09-28 |
AU670962B2 (en) | 1996-08-08 |
NO951163L (no) | 1995-03-27 |
IL107066A0 (en) | 1993-12-28 |
HU9500891D0 (en) | 1995-05-29 |
IL107066A (en) | 1998-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Silveira et al. | Putative M2 muscarinic receptors of rat heart have high affinity for organophosphorus anticholinesterases | |
Akera | Membrane Adenosinetriphosphatase: A Digitalis Receptor? The enzyme is a good model for receptor binding studies because of its known functional correlates. | |
LeRoy et al. | Pharmacokinetic study of cis-dichlorodiammineplatinum (II)(DDP) in the beagle dog: thermodynamic and kinetic behavior of DDP in a biologic milieu | |
TWI268923B (en) | N6 heterocyclic 8-modified adenosine derivatives | |
US5204329A (en) | Treatment of organ transplantation rejection | |
CA2145681A1 (en) | Method for antogonizing inositol 1,4,5-triphosphate | |
JP2002526443A (ja) | 緑内障治療用セロトニン作動性5ht2作用物質 | |
CZ20012340A3 (cs) | Kombinace inhibitorů transportu kyčelní ľlučové kyseliny a proteinových inhibitorů cholesteryl-esterového přenosu pro kardiovaskulární indikace | |
JPH07508731A (ja) | P物質拮抗薬としてのキヌクリジン誘導体 | |
CZ223998A3 (cs) | Derivát 5H-thiazolo/3,2-a/pyrimidinu, způsob jeho přípravy meziprodukt pro jeho přípravu a farmaceutický prostředek, který ho obsahuje | |
Itokawa et al. | Renal and skeletal lesions in experimental cadmium poisoning of rats. Histology and renal function | |
EP0960111B1 (en) | Morphine derivatives with analgesic activity | |
US5763492A (en) | Methods for effecting memory enhancement mediated by non-steroidal sulfatase inhibitors | |
Łażewska et al. | Alkyl derivatives of 1, 3, 5-triazine as histamine H4 receptor ligands | |
Harris et al. | Effects of dihydropyridine derivatives and anticonvulsant drugs on [3H] nitrendipine binding and calcium and sodium fluxes in brain | |
WO1993023035A2 (en) | Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease | |
BRAUN et al. | The attenuation of epinephrine-dependent adenylate cyclase by adenosine and the characteristics of the adenosine stimulatory and inhibitory sites | |
Yamashita et al. | NZ-105, a new 1, 4-dihydropyridine derivative: correlation between dihydropyridine receptor binding and inhibition of calcium uptake in rabbit aorta | |
WO2002050080A1 (en) | Small molecules useful in the treatment of inflammatory disease | |
JPH02503670A (ja) | 1,2,3,4,10,14b‐ヘキサヒドロジベンゾ〔c,f〕ピラジノ〔1,2‐a〕アゼピノ誘導体及び10‐アザ,10‐オキサ及び10‐チア類似体 | |
JP2003512607A (ja) | ムスカリン受容体のアロステリック部位 | |
Lee et al. | Potent enhancement of [3H] nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330 A. | |
Zhang | Muscarinic receptors in developing rat colon | |
Akbulut et al. | Subtypes of muscarinic receptors in rat duodenum A comparison with rabbit vas deferens, rat atria, guinea-pig ileum and gallbladder by using imperialine | |
DE3904795C2 (de) | Pharmazeutisches Präparat und dessen Verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 19990518 |